Evidence map›Paper›PMID 41777339›Full record

ArticleEndoscopy international open2026

Novel "rendez-vous" technique for persistent gastrocutaneous fistula closure.

Zaixian Tee, Arun Abraham, Arash Assadsangabi

Abstract read
In one paragraph

Article in Endoscopy international open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zaixian TeeMedicine, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom of Great Britain and Northern Ireland.
Arun AbrahamGeneral Surgery, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom of Great Britain and Northern Ireland.
Arash AssadsangabiGastroenterology Department, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom of Great Britain and Northern Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and study aims: Gastrocutaneous (GC) fistulas are a rare but challenging adverse event that can occur after removal of a PEG tube 1 . Modern endoscopic techniques such as over-the-scope (OTS) clipping have become popular alternatives over traditional surgical closure for resolving this issue 2 . However, some fistulas fail to close despite endoscopic interventions and would normally require open surgery. Here, we devised a new "rendezvous" method, involving a combination of endoscopic and surgical approaches, to close recalcitrant fistulas. Patients and methods: Four patients with persistent GC fistulas after long-term percutaneous endoscopic gastrostomy (PEG) use were treated with the "rendezvous" technique. This technique utilizes both endoscopic OTS clipping and extraperitoneal surgical excision of the fistula tract to avoid risks of surgery while ensuring fistula closure. Results: The success rates was 100% with no immediate adverse events (AEs) and no recurrences within 2 years of closure in a case series of four patients with persistent GC fistulas. Three of these patients suffered from neurological disorders (cerebral palsy and Parkinson's disease) and required long-term PEG tubes. One patient required long-term PEG feeding following postoperative AE. Conclusions: The novel "rendezvous" technique has showed success in closure of persistent GC fistulas in comorbid patients with long-term PEG use. It is a less-invasive alternative to traditional surgery and produces greater closure rates than endoscopic clipping alone.

Indexed as

Endoscopy Upper GI TractGastrostomy and PEJGI surgeryPerformance and complicationsQuality and logistical aspects

Identifiers

PMID41777339
PMCPMC12951039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.